期刊文献+

河南省结核杆菌药物敏感性试验质量控制结果分析 被引量:6

Quality evaluation on mycobacterium tuberculosis drug susceptibility test in Henan province
下载PDF
导出
摘要 目的评价河南省药敏试验质量。方法按照WHO全球结核病耐药监测药敏试验质量控制要求,分析2001年-2007年WHO结核病跨国参比实验对河南省约敏质量控制的资料。结果河南省2001年-2004年四次药物敏感试验的质量控制结果平均—致性均高于90%;2005-2007年SM、INH、RFP、EMB平均一致性分别为90.0%、97.8%、96.7%和88.9%。结论河南省药敏试验质量已经到达了WHO的要求。 Obective To evaluate the quality of drug susceptibility testing(DST) of MTB in Henan provincial TB reference laboratory.Methods According to quality assurance programme of the global anti-tuberculosis drug resistance surveillance, to analysis proficiency testing results for DST from the WHO/IUATLD supranational reference in 2001-2007.Results the four years mean accordance rate of DST Of four first line anti-tuberculosis drug is all higher than 90 % in2001-2004,the three years mean accordance rate of SM、INH、RFP、EMB is 90.0 %、97.8 %、96.7 %and 88.9 % in2005-2007,respectiVely.Conclusion The quality of DST is credible in Henan provincial TB reference laboratory.
出处 《河南预防医学杂志》 2008年第6期410-411,424,共3页 Henan Journal of Preventive Medicine
关键词 结核杆菌 药物敏感性试验 质量 Mycobacterium Tuberculosis,drug susceptibility testing,quality
  • 相关文献

参考文献3

  • 1杜长梅,王国斌,徐吉英,王国杰,胡惠义,甄新安,李爱华,孙占强,闫国蕊.河南省第二轮结核病耐药监测及耐药趋势研究[J].中国防痨杂志,2006,28(2):95-100. 被引量:26
  • 2WHO/IUATLD Global Working Group OnAntituberculosis Drug ResistanceSurveillance. Guidelines for surveillance of drug resistance in Tuberculosis. Geneva : WHO, 1996.
  • 3A. Laszlo, M. · Rahman, M. Espinal, etal. Quality assurance programme fordrug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network : five rounds of proficiency testing, 1994 - 1998 [ J ]. Int J TubercLung Dis,2002,6 (9) :748 - 756.

二级参考文献9

共引文献25

同被引文献43

  • 1柳正卫,何海波.浙江省第1轮结核分枝杆菌药敏试验室间质量保证结果分析[J].中国防痨杂志,2008,30(1):30-32. 被引量:5
  • 2祖燕,赵富山,闫国蕊.河南省历次结核病流行病学调查分枝杆菌药敏试验结果分析[J].中原医刊,2005,32(16):45-46. 被引量:1
  • 3杜长梅,王国斌,徐吉英,王国杰,胡惠义,甄新安,李爱华,孙占强,闫国蕊.河南省第二轮结核病耐药监测及耐药趋势研究[J].中国防痨杂志,2006,28(2):95-100. 被引量:26
  • 4Alan R. Hinman, James M. Hughes, Dixie E. Snider. Meeting the challenge of multidrug - resistant tuberculosis: summary of a conference[C]. MMWR Recomm Rep, 1992, 19, 41(RR-11) :51 -57.
  • 5American Thoracic Society,CDC and Infectious Diesease Society of America. (2003) Treament of tuberculosis MMWR Recommendations and Reports,52,1 - 77.
  • 6Luna, J. C. (2004)A Tuberculosis Guide for Specialist Physicians, International Union Against Tuberculosis and Lung Disease, Paris.
  • 7Global tuberculosis report control (surveillance, planning, financing). Gevena, WHO/HTM/TB/2008, 393.
  • 8中华人民共和国卫生部.全国结核病耐药基线调查报告(2007-2008年)[R].北京:人民卫生出版社,2010.
  • 9Stefan H. E. Kaufmann, Eric Rubin. Handbook of tuberculosis : Molecular Biology and Biochemistry. Germany: WILEY - Verlag GmbH & Co. KGaA,Weinheim(2008).
  • 10Telenti A. Imboden P. Marchesi F. et aL Detection of rifampicin resistance mutations in Myeobaelerium tuberculosis.Laneel. 1993. 341:647 - 650.

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部